Pfizer Says Its COVID-19 Pill Reduces Death, Hospitalization Risk by 89%; Will Submit for FDA Approval Pfizer says that its COVID-19 pill reduced the risk of hospitalization or death by 89 percent in a clinical trial involving adults “at...

The Covid-19 treatment molnupiravir was developed using funding from the National Institutes of Health and the Department of Defense. A FIVE-DAY COURSE of molnupiravir, the new medicine being hailed as a “huge advance” in the treatment of...